Subutanous testosterone therapy in hypogonadal me
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2023/01/049024
- Lead Sponsor
- Dr Nikhil Bhagwat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Adult hypogonadal men >=18 who are already on stable dose of Intramuscular Testosterone Enanthate therapy for more than 3 months duration
1.Coexistent Liver /Renal dysfunction
2.Congestive heart failure
3.History of following within the last 6 months of screening: Myocardial infarction (MI), unstable angina leading to hospitalization, percutaneous coronary intervention, coronary artery bypass graft, uncontrolled cardiac arrhythmia, stroke transient ischemia attack, carotid revascularization, endovascular procedure, or surgical intervention for peripheral vascular disease
4.Systemic infections
5.Positive serology for HIV, hepatitis B or hepatitis C
6.Skin conditions in injection site that could confound injection site assessments.
7.Use of other androgens (DHEA), anabolic steroids, other sex hormones) or other substances/supplements
8.History or current evidence of breast or prostate cancer
9.Elevated prostate-specific antigen (PSA) for age
10.H/o psychiatric illnesses
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method